Investment
Features
FeesSafety
Academy
More
Pluang+

Compare J M Smucker Co (SJM) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

J M Smucker CoTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

J M Smucker Co vs Vir Biotechnology Inc. Common Stock — how do they compare? J M Smucker Co trades at $122 (market cap $12.96B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: J M Smucker Co is far larger — about 7.2× Vir Biotechnology Inc. Common Stock's market cap, and J M Smucker Co pays a 3.69% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold J M Smucker Co for 74 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

SJMVIR
Market Cap
$12.96B$1.80B
Volume
1,039,2891,782,836
Sector
Consumer StaplesHealth
52-Week High
$132.34$11.78
52-Week Low
$89.53$5.12
Typical Hold Time
74 Days0 Days
Enterprise Value
$19.81B$1.36B
Dividend Yield
3.69%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

J M Smucker Co

SJM trades at $121.84, up 1.52% today, with a bullish technical signal and strong recent earnings beats. The company reported Q2 2026 EPS of $3.24, beating expectations, and raised FY27 guidance. However, 2025 fundamentals show a net loss of $1.23B and elevated P/E of 56.7, while analyst consensus is a Buy with a $138.23 price target.

Outlook is mixed; robust growth in segments like Uncrustables and raised guidance support upside, but high valuation, volatile profitability, and debt levels pose risks. The stock offers a dividend yield but faces competitive and margin pressures in the consumer staples sector.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SJM

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About J M Smucker Co

J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.

Read more on SJM →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →